Judd Jessup has over 35 years of experience in the healthcare and managed care industries. Most recently he was Chief Executive Officer of US LABS, a national laboratory which provides cancer diagnostic and genetic testing services, from 2002 to 2005. He has extensive background in the managed care industry having served as President of the Health Plans Division for FHP International from 1994 to 1996 as well as the President of TakeCare, Inc., a publicly traded HMO operating in California, Colorado, Illinois and Ohio until it was sold to FHP. He is a successful entrepreneur with the ability to execute strategic plans to achieve the optimum level of performance for stakeholders. He has repeatedly built effective management teams utilizing his effective leadership and management style. Mr. Jessup currently serves on the Board of Directors of Corvel Corporation and NovaMed, Inc, both publicly traded companies.

Dr. Gottlieb was appointed to our board of directors in January 2009. He is a former U.S. Food and Drug Administration (FDA) Deputy Commissioner and a leading expert in healthcare policy whose work focuses on providing insights into the economic, regulatory, and technological forces driving the transformation of medicine. Dr. Gottlieb is currently a Resident Fellow at the American Enterprise Institute, a private, nonpartisan, not-for-profit institution dedicated to research and education on issues of government, politics, economics and social welfare. He also practices medicine as an attending physician in Connecticut. Dr. Gottlieb has received numerous awards and is the author of more than 300 articles that have appeared in leading medical journals and publications including The Wall Street Journal and The New York Times. In addition, he has held editorial positions at the British Medical Journal and the Journal of the American Medical Association. Dr. Gottlieb also regularly appears as an expert commentator on CNBC, Fox News, Bloomberg Television, and other business and news channels. Dr. Gottlieb is a partner at Arcoda Capital Management and a venture partner at New Enterprise Associates. He completed his residency in internal medicine at the Mount Sinai Hospital in New York City and is a graduate of the Mount Sinai School of Medicine and of Wesleyan University in Connecticut.

Jeremy M. Jones was appointed to our Board on November 20, 2012 and is also a member of our Audit Committee.  Mr. Jones, 70, is the Chairman of On Assignment, Inc., a publicly traded professional staffing firm, where he has served as a director since May 1995.  Mr. Jones has been an investor and business development consultant since February 1998.  From 1987 to 1995, Mr. Jones was Chief Executive Officer and Chairman of the Board of Homedco Group, Inc., a home healthcare services company, which became publicly traded in 1991.  Homedco merged into Apria Healthcare Group, Inc. in 1995 and from 1995 through January 1998, Mr. Jones was Chief Executive Officer and Chairman of the Board of Apria Healthcare Group, Inc., which also provided home healthcare services.  Mr. Jones served as Chairman of the Board of Byram Healthcare Centers, a provider of retail medical supplies and wholesale medical and hospital equipment, from February 1999 until its sale in March of 2008.  Mr. Jones was a director for Access Point Medical from May 2004 to December 2005.  Mr. Jones was a director of US Labs, an esoteric oncology and hematopathology laboratory from November 2003 through February 2005.  From July 2003 to January 2011, Mr. Jones served as a director for Lifecare Solutions, Inc., a provider of integrated home healthcare products and services.  Mr. Jones holds a bachelor’s degree in business administration from the University of Iowa.